Get the Stockscreener App
8.30
0.00%
0.00
Pre-market:
8.69
0.39
+4.70%
Cero Therapeutics Holdings Inc stock is traded at $8.30, with a volume of 24,172.
It is up +0.00% in the last 24 hours and down -1.78% over the past month.
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
See More
Previous Close:
$8.30
Open:
$8.19
24h Volume:
24,172
Relative Volume:
0.02
Market Cap:
$10.00M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.75%
1M Performance:
-1.78%
6M Performance:
-98.84%
1Y Performance:
-99.85%
1-Day Range:
$8.1663
$8.4964
1-Week Range:
$7.79
$8.90
52-Week Range:
$6.71
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Name
Cero Therapeutics Holdings Inc
Sector
Industry
Phone
650-407-2376
Address
201 HASKINS WAY, SOUTH SAN FRANCISCO
Compare CERO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
8.30 | 10.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Upgrade | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Stock (CERO) Latest News
CERo Therapeutics announces 1-for-20 reverse stock split effective June 13 - MSN
Short Interest Drops in CERo Therapeutics Holdings Inc. After Rally2025 Market Overview & Accurate Trade Setup Notifications - metal.it
CERo Therapeutics Delays 10-Q Filing Amid Valuation Issues - TipRanks
Is CERo Therapeutics Holdings Inc. undervalued by DCF analysisJuly 2025 Chart Watch & Stock Market Timing Techniques - newsyoung.net
Will CERo Therapeutics Holdings Inc. benefit from macro trendsWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Analyzing CERo Therapeutics Holdings Inc. with multi timeframe chartsJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Best data tools to analyze CERo Therapeutics Holdings Inc. stockJuly 2025 PreEarnings & Growth-Oriented Investment Plans - Newser
Risk adjusted return profile for CERo Therapeutics Holdings Inc. Equity Warrant analyzedTrade Exit Summary & Safe Entry Zone Identification - Newser
CERo Therapeutics Holdings Inc. Sees Relief Buying After Extended DropJuly 2025 Weekly Recap & Stepwise Trade Signal Guides - sundaytimes.kr
Chartists Watching For Breakout in CERo Therapeutics Holdings Inc.Weekly Stock Report & Verified Technical Trade Signals - beatles.ru
Top Risks to Consider Before Buying CERo Therapeutics Holdings Inc. Stock2025 Momentum Check & Smart Swing Trading Techniques - Newser
What makes CERo Therapeutics Holdings Inc. stock price move sharplyWeekly Gains Report & Daily Oversold Bounce Ideas - Newser
What Technical Tools Say About CERo Therapeutics Holdings Inc. Recovery - 선데이타임즈
How high can CERo Therapeutics Holdings Inc. Equity Warrant stock goMarket Movers & Consistent Growth Equity Picks - Newser
What moving averages say about CERo Therapeutics Holdings Inc. [CPI Data]Stepwise Trade Execution Plans - Newser
What’s the RSI of CERo Therapeutics Holdings Inc. stockFree Top 5 Picks of the Week - classian.co.kr
CERo Therapeutics CERO 2025Q2 Earnings Preview Downside Risk Amid Regulatory Challenges - AInvest
CERo Therapeutics WRT CEROW 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Up 94.5% in July - Defense World
WINT 8-K: Audit Chair Resigns, New Independent Director Appointed | WINT SEC FilingForm 8-K - Stock Titan
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split - ADVFN Brasil
Does CERo Therapeutics Holdings Inc. Equity Warrant show high probability of reboundPrice Action Trading with Volume Confirmation - Newser
CERo Therapeutics: D. Boral Capital Raises PT to $30 from $30 - AInvest
What is the risk reward ratio of investing in CERo Therapeutics Holdings Inc. Equity Warrant stock - Jammu Links News
What are the technical indicators suggesting about CERo Therapeutics Holdings Inc. Equity WarrantGet daily updates on promising stocks - Jammu Links News
Does CERo Therapeutics Holdings Inc. Equity Warrant stock perform well during market downturnsRapid capital growth - Jammu Links News
How volatile is CERo Therapeutics Holdings Inc. Equity Warrant stock compared to the marketMassive stock growth - Jammu Links News
How does CERo Therapeutics Holdings Inc. compare to its industry peersExceptional gains - Jammu Links News
Is CERo Therapeutics Holdings Inc. stock overvalued or undervaluedHigh-octane gains - Jammu Links News
Does CERo Therapeutics Holdings Inc. stock perform well during market downturnsBuild wealth faster with expert stock selection - Jammu Links News
What makes CERo Therapeutics Holdings Inc. Equity Warrant stock price move sharplyRapid growth trajectories - Jammu Links News
What is CERo Therapeutics Holdings Inc. company’s growth strategyBreakthrough stock performance - Jammu Links News
What are the latest earnings results for CERo Therapeutics Holdings Inc. Equity WarrantBuild a diversified portfolio for steady growth - Jammu Links News
How does CERo Therapeutics Holdings Inc. Equity Warrant compare to its industry peersBuild wealth faster with disciplined trading - Jammu Links News
Is CERo Therapeutics Holdings Inc. Equity Warrant a good long term investment - Jammu Links News
Should I hold or sell CERo Therapeutics Holdings Inc. Equity Warrant stock in 2025Stay ahead with daily expert stock picks - Jammu Links News
Why is CERo Therapeutics Holdings Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
Fibonacci Support Holding Strong in CERo Therapeutics Holdings Inc.Low Risk Buy Zone Opportunity Watch Ongoing - beatles.ru
What are the latest earnings results for CERo Therapeutics Holdings Inc.Spectacular growth rates - Jammu Links News
CERo Therapeutics Holdings Inc. Stock Analysis and ForecastExceptional market performance - Jammu Links News
How does CERo Therapeutics Holdings Inc. Equity Warrant generate profit in a changing economyFree Stock Index Interpretation - Jammu Links News
Is CERo Therapeutics Holdings Inc. Equity Warrant a growth stock or a value stockFree Stock Trend Scanner For 2025 - Jammu Links News
What institutional investors are buying CERo Therapeutics Holdings Inc. stockBest Dividend Updates For Beginners - Jammu Links News
Resistance Break Could Fuel CERo Therapeutics Holdings Inc. RallyReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
CERo doses second patient in Phase 1 AML trial, reports expansion data - Investing.com Australia
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 - GlobeNewswire
Can Traders Expect Breakout From CERo Therapeutics Holdings Inc. This WeekOptimized Watchlist With Daily Adjustments Launched - beatles.ru
Can CERo Therapeutics Holdings Inc. Equity Warrant rally from current levelsAI Screening for Swing Trade Picks Finds Momentum - metal.it
Why CERo Therapeutics Holdings Inc. Equity Warrant stock attracts strong analyst attentionShort Term Risk Analysis Forecast - beatles.ru
Recovery Signals Appearing in CERo Therapeutics Holdings Inc. ChartsEntry Points For Growing Stocks Identified by Models - metal.it
How CERo Therapeutics Holdings Inc. stock performs during market volatilityWeekly Hot Picks With Buy Confidence Released - metal.it
Cero Therapeutics Holdings Inc Stock (CERO) Financials Data
There is no financial data for Cero Therapeutics Holdings Inc (CERO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Cero Therapeutics Holdings Inc Stock (CERO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| YK Bioventures Opportunities G | 10% Owner |
Dec 13 '24 |
Sale |
0.06 |
2,998,908 |
179,934 |
13,005,169 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 12 '24 |
Sale |
0.07 |
1,614,541 |
113,018 |
16,004,077 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 11 '24 |
Sale |
0.08 |
1,343,801 |
107,504 |
17,618,618 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 06 '24 |
Sale |
0.12 |
1,236,874 |
148,425 |
21,383,909 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 10 '24 |
Sale |
0.09 |
1,570,947 |
141,385 |
18,962,419 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 09 '24 |
Sale |
0.11 |
850,543 |
93,560 |
20,533,366 |
| SLOAN STUART M | 10% Owner |
Sep 25 '24 |
Sale |
0.10 |
532,486 |
55,538 |
21,067,956 |
| YK Bioventures Opportunities G | 10% Owner |
Oct 10 '24 |
Sale |
0.10 |
3,250,000 |
325,000 |
22,620,783 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):